Total Marks 5
Starting Date Thursday, August 01, 2019
Closing Date Friday, August 02, 2019
Question Title Sub editing
The job of sub editor is very tough. Elaborate the tasks performed by the sub editor of a magazine before sending it for printing.
Discussion is right way to get Solution of the every assignment, Quiz and GDB.
We are always here to discuss and Guideline, Please Don't visit Cyberian only for Solution.
Cyberian Team always happy to facilitate to provide the idea solution. Please don't hesitate to contact us! NOTE: Don't copy or replicating idea solutions. Quiz Copy Solution Mid and Final Past Papers Live Chat
Since the infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was reported in China during December 2019, the coronavirus disease 2019 (COVID-19) has spread on a global scale, causing the World Health Organization (WHO) to issue a warning. While novel vaccines and drugs that target SARS-CoV-2 are under development, this review provides information on therapeutics which are under clinical trials or are proposed to antagonize SARS-CoV-2. Based on the information gained from the responses to other RNA coronaviruses, including the strains that cause severe acute respiratory syndrome (SARS)-coronaviruses and Middle East respiratory syndrome (MERS), drug repurposing might be a viable strategy. Since several antiviral therapies can inhibit viral replication cycles or relieve symptoms, mechanisms unique to RNA viruses will be important for the clinical development of antivirals against SARS-CoV-2. Given that several currently marketed drugs may be efficient therapeutic agents for severe COVID-19 cases, they may be beneficial for future viral pandemics and other infections caused by RNA viruses when standard treatments are unavailable.
Keywords: COVID-19; coronavirus; infection; drug discovery; drug repositioning